- Home
- ABR vs IMTX Comparison
ABR vs IMTX Comparison
Compare ABR & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABR | IMTX |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | Germany |
| Employees | 653 | 407 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABR | IMTX |
|---|---|---|
| Price | $7.35 | $9.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $10.30 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 3.7M | 527.5K |
| Earning Date | 05-01-2026 | 03-05-2026 |
| Dividend Yield | ★ 16.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $45.15 |
| P/E Ratio | $9.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.11 | $3.30 |
| 52 Week High | $12.58 | $12.41 |
Technical Indicators
Market Signals| Indicator | ABR | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 43.49 |
| Support Level | $7.23 | $8.82 |
| Resistance Level | $7.95 | $10.64 |
| Average True Range (ATR) | 0.22 | 0.54 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 2.22 | 10.54 |
Price Performance
Historical ComparisonAbout ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.